Monument Therapeutics Announces Appointment of Robert Radie as Chair and Heather Preston to Advisory Board
MANCHESTER, England, April 17, 2025 /PRNewswire/ -- Monument Therapeutics, a precision-neuroscience company focused on the development of innovative treatments for serious central nervous system disorders (CNS), today announced two key